Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study

for the Neonatal Diabetes International Collaborative Group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)637-646
JournalThe Lancet Diabetes and Endocrinology
Issue number8
Early online date4 Jun 2018
Publication statusPublished - Aug 2018


  • neonatal diabetes
  • Sulphonylureas

Cite this